Evidence for Anal Dysplasia Treatment

Abstract

Anal dysplasia, primarily caused by high-risk human papillomavirus (HPV) infection, presents as a precursor to anal cancer (AC), especially among high-risk populations such as human immunodeficiency virus (HIV)-positive individuals. This review evaluates evidence for the treatment of anal intraepithelial neoplasia, focusing on recent advancements in the context of the Anal Cancer/HSIL Outcomes Research Study (ANCHOR) trial which demonstrates that active treatment of high-grade squamous intraepithelial lesions markedly reduced progression to AC. This affirms the value of proactive treatment strategies over passive monitoring. Furthermore, we will discuss various treatment modalities, including topical agents, electrocautery, and HPV vaccination, and their efficacy and limitations. This review underscores the necessity of integrating screening and targeted interventions, particularly for high-risk groups, to reduce AC incidence. Future research should aim to validate these findings across broader demographic groups, refining public health policies and clinical guidelines to include effective screening and treatment protocols.

Keywords

anal dysplasia - high-resolution anoscopy - human papillomavirus - anal intraepithelial neoplasia

Publication History

Article published online:
01 July 2025

• References

• 1 Chesson HW, Dunne EF, Hariri S, Markowitz LE. The estimated lifetime probability of acquiring human papillomavirus in the United States. Sex Transm Dis 2014; 41 (11) 660-664
• 2 Hoots BE, Palefsky JM, Pimenta JM, Smith JS. Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer 2009; 124 (10) 2375-2383
• 3 Deshmukh AA, Suk R, Shiels MS. et al. Recent trends in squamous cell carcinoma of the anus incidence and mortality in the United States, 2001-2015. J Natl Cancer Inst 2020; 112 (08) 829-838
• 4 U.S. Census Bureau. Census Bureau Projects U.S. and World Populations on New Year's Day. Accessed June 9, 2025 at: https://www.commerce.gov/news/blog/2024/01/census-bureau-projects-us-and-world-populations-new-years-day
• 5 Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin 2024; 74 (01) 12-49
• 6 Palefsky JM, Lee JY, Jay N. et al.; ANCHOR Investigators Group. Treatment of anal high-grade squamous intraepithelial lesions to prevent anal cancer. N Engl J Med 2022; 386 (24) 2273-2282
• 7 Ortholan C, François E, Gérard J-P. Preneoplastic anal lesions and anal canal carcinoma [in French]. Bull Cancer 2003; 90 (05) 405-411
• 8 Egawa N, Egawa K, Griffin H, Doorbar J. Human papillomaviruses; epithelial tropisms, and the development of neoplasia. Viruses 2015; 7 (07) 3863-3890
• 9 Abramowitz L, Benabderrahmane D, Ravaud P. et al. Anal squamous intraepithelial lesions and condyloma in HIV-infected heterosexual men, homosexual men and women: prevalence and associated factors. AIDS 2007; 21 (11) 1457-1465
• 10 Peña N, Carrillo D, Muñoz JP. et al. Tobacco smoke activates human papillomavirus 16 p97 promoter and cooperates with high-risk E6/E7 for oxidative DNA damage in lung cells. PLoS ONE 2015; 10 (04) e0123029
• 11 Marra E, Lin C, Clifford GM. Type-specific anal human papillomavirus prevalence among men, according to sexual preference and HIV status: A systematic literature review and meta-analysis. J Infect Dis 2019; 219 (04) 590-598
• 12 Weiss W, Hanak H, Huber A. Effizienz der rektal-digitalen Untersuchung zur Früherkennung des Dickdarmkarzinoms. [Clinical value of rectal digital examination in early diagnosis of colorectal cancer (author's transl)] [in German]. Wien Klin Wochenschr 1977; 89 (19) 654-660
• 13 Maia LB, Marinho LC, Wanderley Paes Barbosa T. et al. A comparative study between conventional and liquid-based cytology in screening for anal intraepithelial lesions in HIV-positive patients. Diagn Cytopathol 2014; 42 (10) 840-845
• 14 Maia LB, Marinho LC, Barbosa TW. et al. Value of human papillomavirus typing for detection of anal cytological abnormalities. Indian J Sex Transm Dis AIDS 2013; 34 (02) 102-106
• 15 Stier EA, Clarke MA, Deshmukh AA. et al. International Anal Neoplasia Society's consensus guidelines for anal cancer screening. Int J Cancer 2024; 154 (10) 1694-1702
• 16 Albuquerque A. High-resolution anoscopy: Unchartered territory for gastroenterologists?. World J Gastrointest Endosc 2015; 7 (13) 1083-1087
• 17 Hillman RJ, Cuming T, Darragh T. et al. 2016 IANS International Guidelines for practice standards in the detection of anal cancer precursors. J Low Genit Tract Dis 2016; 20 (04) 283-291
• 18 Darragh TM, Colgan TJ, Thomas Cox J. et al.; Members of the LAST Project Work Groups. The Lower Anogenital Squamous Terminology Standardization project for HPV-associated lesions: Background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Int J Gynecol Pathol 2013; 32 (01) 76-115
• 19 Barquet-Muñoz SA, López-Morales RA, Stier EA. et al. Prevalence of anal high-risk human papillomavirus (HR-HPV) types in people living with HIV and a history of cancer. HIV Med 2024; 25 (10) 1145-1153
• 20 Batman S, Messick CA, Milbourne A. et al. A cross-sectional study of the prevalence of anal dysplasia among women with high-grade cervical, vaginal, and vulvar dysplasia or cancer: The PANDA study. Cancer Epidemiol Biomarkers Prev 2022; 31 (12) 2185-2191
• 21 Madeleine MM, Finch JL, Lynch CF, Goodman MT, Engels EA. HPV-related cancers after solid organ transplantation in the United States. Am J Transplant 2013; 13 (12) 3202-3209
• 22 Durukan D, Phillips TR, Murray GL. et al. Intra-anal Imiquimod cream against human papillomavirus infection in men who have sex with men living with HIV: A single-arm, open-label pilot study. J Clin Med 2021; 10 (19) 4477
• 23 Ceilley RI. Mechanisms of action of topical 5-fluorouracil: review and implications for the treatment of dermatological disorders. J Dermatolog Treat 2012; 23 (02) 83-89
• 24 Snyder SM, Siekas L, Aboulafia DM. Initial experience with topical fluorouracil for treatment of HIV-associated anal intraepithelial neoplasia. J Int Assoc Physicians AIDS Care (Chic) 2011; 10 (02) 83-88
• 25 Richel O, Wieland U, de Vries HJC. et al. Topical 5-fluorouracil treatment of anal intraepithelial neoplasia in human immunodeficiency virus-positive men. Br J Dermatol 2010; 163 (06) 1301-1307
• 26 Singh JC, Kuohung V, Palefsky JM. Efficacy of trichloroacetic acid in the treatment of anal intraepithelial neoplasia in HIV-positive and HIV-negative men who have sex with men. J Acquir Immune Defic Syndr 2009; 52 (04) 474-479
• 27 Richel O, de Vries HJ, van Noesel CJ, Dijkgraaf MG, Prins JM. Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial. Lancet Oncol 2013; 14 (04) 346-353
• 28 Ghelardi A, Parazzini F, Martella F. et al. SPERANZA project: HPV vaccination after treatment for CIN2. Gynecol Oncol 2018; 151 (02) 229-234
• 29 Athanasiou A, Bowden S, Paraskevaidi M. et al. HPV vaccination and cancer prevention. Best Pract Res Clin Obstet Gynaecol 2020; 65: 109-124
• 30 De Vincenzo R, Ricci C, Conte C, Scambia G. HPV vaccine cross-protection: Highlights on additional clinical benefit. Gynecol Oncol 2013; 130 (03) 642-651
• 31 Paradkar PH, Joshi JV, Mertia PN, Agashe SV, Vaidya RA. Role of cytokines in genesis, progression and prognosis of cervical cancer. Asian Pac J Cancer Prev 2014; 15 (09) 3851-3864
• 32 Siddharthan RV, Lanciault C, Tsikitis VL. Anal intraepithelial neoplasia: diagnosis, screening, and treatment. Ann Gastroenterol 2019; 32 (03) 257-263
• 33 Goldstone RN, Goldstone AB, Russ J, Goldstone SE. Long-term follow-up of infrared coagulator ablation of anal high-grade dysplasia in men who have sex with men. Dis Colon Rectum 2011; 54 (10) 1284-1292
• 34 Deshmukh AA, Damgacioglu H, Georges D, Sonawane K, Clifford GM. Human papillomavirus-associated anal cancer incidence and burden among US men, according to sexual orientation, human immunodeficiency virus status, and age. Clin Infect Dis 2023; 77 (03) 419-424
• 35 Clifford GM, Georges D, Shiels MS. et al. A meta-analysis of anal cancer incidence by risk group: Toward a unified anal cancer risk scale. Int J Cancer 2021; 148 (01) 38-47